Ben-Gary Harvey, M.D.
“My main objective is to provide the best possible medical care to individuals affected by lung diseases. I believe that an open conversation with patients in combination with a thorough physical examination and ancillary testing represents the fundamental steps in understanding lung diseases and the impact of these diseases in the quality of lives of the affected individuals. "
Dr. Harvey is Board Certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine. He is the Director of the Bronchoscopy and Procedure Services in the Pulmonary Division. Under his direction, the Pulmonary Division offers a variety of advanced pulmonary procedures including bronchoscopy with lavage, biopsies, endobronchial ultrasound guided biopsy of mediastinal masses and enlarged mediastinal lymph nodes; endobronchial hot and cold therapies for airway diseases and trachea- bronchial stent placement. Similarly, the Procedure Service offers management of pleural effusions with thoracentesis, insertion of chest tubes and insertion and management of indwelling pleural catheters for the management of persistent pleural effusions.
Linked to the Pulmonary Procedure Service, Dr. Harvey has a special outpatient office session dedicated to the evaluation and management of individuals with lung nodules and lung masses.
For the past decade, Dr. Harvey has been engaged in the assessment and management of individuals with pulmonary hypertension. In this regard, Dr. Harvey provides outpatient and inpatient care including critical care management to individuals affected by this disease.
Internship: Jamaica Hospital, Queens, NY
Residency: State University of New York Downstate Medical Center, Kings County Hospital, and Veteran Administration Medical Center, Brooklyn, NY
Fellowship: Division of Pulmonary and Critical Care Medicine-Weill Medical College of Cornell University/New York Presbyterian Hospital, New York, NY
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.
- AETNA [PPO]
- AETNA [HMO]
- AETNA [Medicare]
- Aetna - Weill Cornell [POS]
- Affinity Health Plan
- Empire Blue Cross/Blue Shield [HMO]
- Empire Blue Cross/Blue Shield [EPO]
- Empire Blue Cross/Blue Shield [PPO]
- Empire Blue Cross/Blue Shield [Mediblue (Senior)]
- Fidelis Care
- Health First
- Health Insurance Plan of NY (HIP)
- Health Insurance Plan of NY (HIP) [Medicare]
- Health Insurance Plan of NY (HIP) [Medicaid]
- Health Plus - Amerigroup
- Medicare [Medicare]
- Oxford Health Plans [Freedom]
- Oxford Health Plans [Liberty]
- Oxford Health Plans [Medicare Advantage]
- Rockefeller University - CoreSource
- United Empire
- United Health Care
- United Health Care [Medicare]
- United Health Care [Community Plan]
Vincent T, Harvey B-G, Hogan SM, Bailey CJ, Crystal RG, Leopold PL. Rapid assessment of adenovirus serum neutralizing antibody titer based on quantitative, morphometric evaluation of capsid binding and intracellular trafficking. J Virol 2001; 75: 1516-1521.
Harvey B-G, Hackett NR, Ely S, Crystal RG. Host responses and persistence of vector genome following intrabronchial administration of an E1-E3- adenovirus gene transfer vector to normal individuals. Molecular therapy 2001; 3: 206-215.
Crystal RG, Harvey B-G, Wisnivesky JP, O#146;Donoghue KA, Chu KW, Maroni J, Muscat JC, Pippo AL, Wright CE, Kaner RJ, Leopold PL, Kessler PD, Rasmussen HS, Rosengart TK, Hollmann C. Analysis of risk factors for local delivery of low and intermediate dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther 2002; 13: 65-100.
Harvey B-G, Maroni J, O#146;Donoghue K, Chu K, Muscat J, Pippo A, Wright C, Hollmann C, Wisnivesky J, Kessler PD, Rasmussen HS, Rosengart TK, Crystal RG. Safety of local delivery of low and intermediate dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther 2002; 13: 15-65.
Harvey B-G, McKinney RL., Rosengart, T., Lesser ML., and Crystal RG. Systemic Interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes. Molecular Therapy 2002; 6: 287-297
Hackett NR, Heguy A, Harvey B-G, Luettich K, Kaplan R, Crystal RG. Individual variability of gene expression in the human airway epithelium responding to the stress of cigarette smoking. American Journal of Respiratory Cell and Molecular Biology 2003; 29:332-343.
Kaplan R, Luettich K, Heguy A, Hackett NR, Harvey B-G, Crystal RG. Monoallelic upregulation of the imprinted H19 gene in airway epithelium of phenotypically normal cigarette smokers. Cancer Research 2003; 63: 1475-1482.
Heguy A, Harvey B-G, O#146;Connor TP, Hackett NR, Crystal RG. Sampling dependent upregulation of gene expression in sequential samples of human airway epithelial cells. Mol Med 2003; 9: 200-208.
Worgall S, Heguy A, Kuettich K, O'Connor TP, Harvey B-G, Quadri LEN, Crystal RG. Similarity of patterns in gene expression of human alveolar macrophages evoked by Pseudomonas aeruginosa and Burkholderia cepacia. Infect Immun 2005; 73: 5262-5268.
Heguy A, O'Connor TP, Luettich K, Worgall S, Cieciuch AA, Harvey B-G, Hackett NR, Crystal RG. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and non-smokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 2006; 84:318-328.
Harvey B-G, Heguy A, Leopold PL, Ferris B, Crystal RG. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med 2007; 86:39-53.
Carolan BJ, Heguy A, Harvey B-G, Leopold PL, Ferris B. Upregulation of expression of the ubiquitin carboxyl terminal hydrolase L 1 gene in human airway epithelium of cigarette smokers. Ca Res 2006; 66:10729-10740
Heguy A, Harvey B-G, Leopold PL, Dolgalev I, Raman T, Crystal RG. Related responses of the human airway epithelium transcriptome to in vivo injury. Physiol Genomics 2007; 29:139-148.
Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, O'Connor TP, Harvey BG, Crystal RG. Variability in small airway epithelial gene expression among normal
smokers. Chest. 2008 Jun;133(6):1344-53. Epub 2008 Mar 13. PubMed PMID: 18339782.
Kazeros A, Harvey BG, Carolan BJ, Vanni H, Krause A, Crystal RG.
Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages
of cigarette smokers. Am J Respir Cell Mol Biol. 2008 Dec;39(6):747-57. Epub 2008
Jun 27. PubMed PMID: 18587056; PubMed Central PMCID: PMC2586050.
Carolan BJ, Harvey BG, De BP, Vanni H, Crystal RG. Decreased expression of
intelectin 1 in the human airway epithelium of smokers compared to nonsmokers. J
Immunol. 2008 Oct 15;181(8):5760-7. PubMed PMID: 18832735; PubMed Central PMCID: PMC2651682.
Tilley AE, Harvey BG, Heguy A, Hackett NR, Wang R, O'Connor TP, Crystal RG.
Down-regulation of the notch pathway in human airway epithelium in association
with smoking and chronic obstructive pulmonary disease. Am J Respir Crit Care
Med. 2009 Mar 15;179(6):457-66. Epub 2008 Dec 23. PubMed PMID: 19106307; PubMed Central PMCID: PMC2654975.
Vanni H, Kazeros A, Wang R, Harvey BG, Ferris B, De BP, Carolan BJ, Hübner RH,
O'Connor TP, Crystal RG. Cigarette smoking induces overexpression of a
fat-depleting gene AZGP1 in the human. Chest. 2009 May;135(5):1197-208. Epub 2009
Feb 2. PubMed PMID: 19188554; PubMed Central PMCID: PMC2679098.
Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O'Connor TP,
Crystal RG. Smoking-dependent reprogramming of alveolar macrophage polarization:
implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol.
2009 Aug 15;183(4):2867-83. Epub 2009 Jul 27. PubMed PMID: 19635926.
Honors and Awards
American Thoracic Society, International Conference, 2007
Scientific Breakthroughs of the Year, ÂAirway Epithelial Resistance to Smoking: Differences in Small Airway Epithelium Gene Expression in Healthy Individuals with High Pack-yr
History vs Individuals with an Early COPD Phenotype with Low Pack-yr HistoryÂ
James P. Smith Clinical Scholar (2007-Present)
Fellow, Stony-Wold Herbert Fund, Inc.(1999-Present)
Stonywall Herbert Research Fellow (1993)
Distinguished Student, Medical School Fundacion Universidad Del Norte, Colombia (1985)
Distinguished Student, DivisiÃ³n de Ciencias de la Salud-
Medicina, Fundacion Universidad del Norte (1979-1982)
- Pulmonary Disease Medicine
- Pulmonary Medicine
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung Cancer
- Chronic Bronchitis
- Cystic Fibrosis
- Pulmonary Embolism
- Mechanical Ventilation
Contact and Practices
- Pulmonary Disease Medicine
- Critical Care Medicine
- Internal Medicine
- M.D., Fundacion Universidad del Norte (Colombia), 1985